New Year Bumper Sale @ Rs. 1 X
Pentariv D is a prescription drug, available for use as Tablet. Pentariv D also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Pentariv D. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Pentariv D also has some side effects, the most common being Headache, Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Pentariv D as well, which are listed below. Such side effects of Pentariv D normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Pentariv D's effect during pregnancy is Severe and Severe while nursing. It is important to know if Pentariv D has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pentariv D related warnings section.
Individuals suffering from medical conditions like Liver Disease, Osteoporosis, Kidney Disease must refrain from the use of Pentariv D since this can cause severe adverse effects.
Besides this, Pentariv D may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Pentariv D is not safe while driving, and is is not addictive in nature.
Pentariv D is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Pentariv D safe for pregnant women?
Pentariv D shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Pentariv D safe during breastfeeding?
Taking Pentariv D may lead to serious side effects if you are breastfeeding. Pentariv D should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Pentariv D on the Kidneys?
There can be some harmful effects on your kidneys after taking Pentariv D. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Pentariv D on the Liver?
The liver can be affected by Pentariv D. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Pentariv D only after medical advice.
What is the effect of Pentariv D on the Heart?
Very few cases of side effects of Pentariv D on the heart have been reported.
Pentariv D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pentariv D unless your doctor advises you to do so -
Is this Pentariv D habit forming or addictive?
Pentariv D does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Pentariv D can make you feel drowsy.
Is it safe?
Yes, Pentariv D is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Pentariv D cannot treat any kind of mental disorder.
Interaction between Food and Pentariv D
There is no information on the effects of taking Pentariv D with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Pentariv D
Due to lack of research, there is no information about the side effects of taking Pentariv D with alcohol.
No, Pentariv D does not cause high blood sugar (hyperglycemia). It has not been reported by the patients who are taking it. You are advised to monitor your blood sugar level on daily basis. If you notice high blood sugar levels after taking this drug, then discuss it with your doctor who might change the dosage of your current medications.
No, Pentariv D should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Pentariv D can cause constipation. It is a rare side effect of this drug. However, if you are experiencing severe constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
No, Pentariv D does not causes bloating (swollen belly after eating food which might be caused by excessive gas production). It has not been reported by the patients who are taking it. If you are experiencing bloating after taking this medicine, then try eating less spicy and fibre rich food also try to eat food in less quantity at a time. Taking probiotics or digestive enzyme supplements might be helpful in reducing bloating.
Yes, Pentariv D has been reported to cause rashes or itching but this occurs in a few cases only. It is a common side effect of this medicine. If you experience excessive itching then consult it with your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Protonix (pantoprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 984-986